To examine whether the function of xCT is also essential for the glucose-deprivation-increased ROS levels and glucose-deprivation-induced cell death of the breast cancer cells with an SIRT3 knockdown, we treated the SIRT3 knockdown cells with the xCT inhibitor SSA. Here, SLC7A11 is linked to breast cancer.